Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology.

Sato Y, Suzuki I, Nakamura T, Bernier F, Aoshima K, Oda Y.

J Lipid Res. 2012 Mar;53(3):567-76. doi: 10.1194/jlr.M022376. Epub 2011 Dec 27.

2.

Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.

Inoue K, Tsuchiya H, Takayama T, Akatsu H, Hashizume Y, Yamamoto T, Matsukawa N, Toyo'oka T.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jan 1;974:24-34. doi: 10.1016/j.jchromb.2014.10.022. Epub 2014 Oct 27.

PMID:
25463194
3.

Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease.

Sato Y, Bernier F, Yamanaka Y, Aoshima K, Oda Y, Ingelsson M, Lannfelt L, Miyashita A, Kuwano R, Ikeuchi T.

Alzheimers Dement (Amst). 2015 Mar 29;1(1):67-74. doi: 10.1016/j.dadm.2014.11.009. eCollection 2015 Mar.

4.

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.

Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR, Welsh-Bohmer KA, Doraiswamy PM, Kaddurah-Daouk R.

PLoS One. 2011;6(7):e21643. doi: 10.1371/journal.pone.0021643. Epub 2011 Jul 11.

5.

Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.

Wang G, Zhou Y, Huang FJ, Tang HD, Xu XH, Liu JJ, Wang Y, Deng YL, Ren RJ, Xu W, Ma JF, Zhang YN, Zhao AH, Chen SD, Jia W.

J Proteome Res. 2014 May 2;13(5):2649-58. doi: 10.1021/pr5000895. Epub 2014 Apr 14.

PMID:
24694177
6.

Alterations of cholesterol precursor levels in Alzheimer's disease.

Kölsch H, Heun R, Jessen F, Popp J, Hentschel F, Maier W, Lütjohann D.

Biochim Biophys Acta. 2010 Aug;1801(8):945-50. doi: 10.1016/j.bbalip.2010.03.001. Epub 2010 Mar 11.

PMID:
20226877
7.

Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.

Huan T, Tran T, Zheng J, Sapkota S, MacDonald SW, Camicioli R, Dixon RA, Li L.

J Alzheimers Dis. 2018;65(4):1401-1416. doi: 10.3233/JAD-180711.

PMID:
30175979
8.

Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease.

Proitsi P, Kim M, Whiley L, Pritchard M, Leung R, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Sham P, Lovestone S, Powell JF, Dobson RJ, Legido-Quigley C.

Transl Psychiatry. 2015 Jan 13;5:e494. doi: 10.1038/tp.2014.127.

9.

Alzheimer's disease: brain desmosterol levels.

Wisniewski T, Newman K, Javitt NB.

J Alzheimers Dis. 2013;33(3):881-8. doi: 10.3233/JAD-2012-121453.

10.

A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.

Olazarán J, Gil-de-Gómez L, Rodríguez-Martín A, Valentí-Soler M, Frades-Payo B, Marín-Muñoz J, Antúnez C, Frank-García A, Acedo-Jiménez C, Morlán-Gracia L, Petidier-Torregrossa R, Guisasola MC, Bermejo-Pareja F, Sánchez-Ferro Á, Pérez-Martínez DA, Manzano-Palomo S, Farquhar R, Rábano A, Calero M.

J Alzheimers Dis. 2015;45(4):1157-73. doi: 10.3233/JAD-142925.

PMID:
25649659
11.

Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.

Shah DJ, Rohlfing F, Anand S, Johnson WE, Alvarez MT, Cobell J, King J, Young SA, Kauwe JS, Graves SW.

J Alzheimers Dis. 2016;49(2):317-27. doi: 10.3233/JAD-150498.

PMID:
26484917
12.

A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.

Greenberg N, Grassano A, Thambisetty M, Lovestone S, Legido-Quigley C.

Electrophoresis. 2009 Apr;30(7):1235-9. doi: 10.1002/elps.200800589.

PMID:
19288586
13.

Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry.

Li NJ, Liu WT, Li W, Li SQ, Chen XH, Bi KS, He P.

Clin Biochem. 2010 Aug;43(12):992-7. doi: 10.1016/j.clinbiochem.2010.04.072. Epub 2010 May 10.

PMID:
20457143
14.

Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics.

Cui Y, Liu X, Wang M, Liu L, Sun X, Ma L, Xie W, Wang C, Tang S, Wang D, Wu Q.

J Neuropathol Exp Neurol. 2014 Oct;73(10):954-63. doi: 10.1097/NEN.0000000000000116.

PMID:
25192049
15.

Measurement of Blood Thiamine Metabolites for Alzheimer's Disease Diagnosis.

Pan X, Fei G, Lu J, Jin L, Pan S, Chen Z, Wang C, Sang S, Liu H, Hu W, Zhang H, Wang H, Wang Z, Tan Q, Qin Y, Zhang Q, Xie X, Ji Y, Cui D, Gu X, Xu J, Yu Y, Zhong C.

EBioMedicine. 2015 Nov 26;3:155-162. doi: 10.1016/j.ebiom.2015.11.039. eCollection 2016 Jan.

16.

Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.

Oh J, Lee HJ, Song JH, Park SI, Kim H.

Exp Gerontol. 2014 Dec;60:87-91. doi: 10.1016/j.exger.2014.10.004. Epub 2014 Oct 8.

PMID:
25304332
17.

Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.

González-Domínguez R, García-Barrera T, Gómez-Ariza JL.

Anal Bioanal Chem. 2014 Nov;406(28):7137-48. doi: 10.1007/s00216-014-8102-3. Epub 2014 Sep 18.

PMID:
25230597
18.

A Novel Plasma Based Biomarker of Alzheimer's Disease.

Bradley-Whitman MA, Abner E, Lynn BC, Lovell MA.

J Alzheimers Dis. 2015;47(3):761-71. doi: 10.3233/JAD-150183.

PMID:
26401710
19.

Serum lipid levels in patients with Alzheimer's disease.

Presećki P, Mück-Seler D, Mimica N, Pivac N, Mustapić M, Stipcević T, Smalc VF.

Coll Antropol. 2011 Jan;35 Suppl 1:115-20.

PMID:
21648320
20.

Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.

Mangialasche F, Solomon A, Kåreholt I, Hooshmand B, Cecchetti R, Fratiglioni L, Soininen H, Laatikainen T, Mecocci P, Kivipelto M.

Exp Gerontol. 2013 Dec;48(12):1428-35. doi: 10.1016/j.exger.2013.09.006. Epub 2013 Oct 7.

PMID:
24113154

Supplemental Content

Support Center